Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event
Clinical trial NCT00552188 · COMPLETED
Trial details
- NCT number
- NCT00552188
- Sponsor
- Tallikut Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-10-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.